Mark M. Udden

2.8k total citations
62 papers, 2.1k citations indexed

About

Mark M. Udden is a scholar working on Physiology, Hematology and Genetics. According to data from OpenAlex, Mark M. Udden has authored 62 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Physiology, 25 papers in Hematology and 21 papers in Genetics. Recurrent topics in Mark M. Udden's work include Erythrocyte Function and Pathophysiology (25 papers), Hemoglobinopathies and Related Disorders (18 papers) and Blood groups and transfusion (14 papers). Mark M. Udden is often cited by papers focused on Erythrocyte Function and Pathophysiology (25 papers), Hemoglobinopathies and Related Disorders (18 papers) and Blood groups and transfusion (14 papers). Mark M. Udden collaborates with scholars based in United States, United Kingdom and Vietnam. Mark M. Udden's co-authors include T. B. Driscoll, Clarence P. Alfrey, Larry V. McIntire, S. G. Eskin, David Sears, LV McIntire, Lawrence Rice, Timothy M. Wick, Yan-Ting Shiu and Joel L. Moake and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Mark M. Udden

60 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark M. Udden United States 24 863 710 674 345 339 62 2.1k
Joan‐Lluís Vives Corrons Spain 23 640 0.7× 585 0.8× 463 0.7× 231 0.7× 213 0.6× 98 1.8k
Tor Olofsson Sweden 33 426 0.5× 1.1k 1.5× 447 0.7× 262 0.8× 420 1.2× 145 3.3k
Claudio Sandoval United States 25 203 0.2× 914 1.3× 559 0.8× 306 0.9× 398 1.2× 92 2.8k
W Fried United States 29 833 1.0× 2.0k 2.8× 957 1.4× 356 1.0× 288 0.8× 119 3.4k
Michael Jeng United States 27 289 0.3× 795 1.1× 494 0.7× 93 0.3× 271 0.8× 92 1.8k
M. C. Brain United Kingdom 29 640 0.7× 1.1k 1.6× 598 0.9× 449 1.3× 141 0.4× 72 2.5k
Louis D. Wadsworth Canada 24 498 0.6× 811 1.1× 463 0.7× 131 0.4× 91 0.3× 69 2.2k
A. J. Bellingham United Kingdom 25 478 0.6× 597 0.8× 687 1.0× 138 0.4× 108 0.3× 79 1.8k
Maurizio Sampietro Italy 31 291 0.3× 1.4k 1.9× 1.2k 1.9× 190 0.6× 99 0.3× 83 3.1k
DG Nathan United States 33 730 0.8× 2.5k 3.5× 1.4k 2.1× 274 0.8× 599 1.8× 101 4.0k

Countries citing papers authored by Mark M. Udden

Since Specialization
Citations

This map shows the geographic impact of Mark M. Udden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark M. Udden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark M. Udden more than expected).

Fields of papers citing papers by Mark M. Udden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark M. Udden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark M. Udden. The network helps show where Mark M. Udden may publish in the future.

Co-authorship network of co-authors of Mark M. Udden

This figure shows the co-authorship network connecting the top 25 collaborators of Mark M. Udden. A scholar is included among the top collaborators of Mark M. Udden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark M. Udden. Mark M. Udden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guffey, Danielle, Rock Bum Kim, Abiodun Oluyomi, et al.. (2024). Clinical outcomes of patients with newly diagnosed large B-cell lymphoma in a safety-net hospital system. PubMed. 1(3). 100020–100020.
2.
Lachowiez, Curtis A., Harinder S. Juneja, Wei Qiao, et al.. (2021). Clinical Outcomes of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia in a County Hospital System. Clinical Lymphoma Myeloma & Leukemia. 21(11). e895–e902. 4 indexed citations
3.
Moake, Joel L., et al.. (2013). Treatment of refractory thrombotic thrombocytopenic purpura with N ‐acetylcysteine: a case report. Transfusion. 54(5). 1221–1224. 43 indexed citations
4.
Sears, David & Mark M. Udden. (2011). Howell-Jolly Bodies: A Brief Historical Review. The American Journal of the Medical Sciences. 343(5). 407–409. 28 indexed citations
5.
Zhou, Zhou, et al.. (2011). Erythrocyte membrane sulfatide plays a crucial role in the adhesion of sickle erythrocytes to endothelium. Thrombosis and Haemostasis. 105(6). 1046–1052. 11 indexed citations
6.
Udden, Mark M.. (2004). Effects of diethylene glycol butyl ether and butoxyethoxyacetic acid on rat and human erythrocytes. Toxicology Letters. 156(1). 95–101. 9 indexed citations
7.
Udden, Mark M., et al.. (2004). Butoxyacetic acid-induced hemolysis of rat red blood cells: effect of external osmolarity and cations. Toxicology Letters. 156(1). 81–93. 12 indexed citations
8.
Vega, Francisco, Chung-Che Chang, Leonard Jeffrey Medeiros, et al.. (2004). Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Modern Pathology. 18(6). 806–815. 254 indexed citations
9.
Manhas, Amit, et al.. (2003). Danaparoid for heparin‐induced thrombocytopenia: an analysis of treatment failures. European Journal Of Haematology. 71(2). 109–113. 32 indexed citations
10.
Massarweh, Suleiman, Mark M. Udden, Imran Shahab, et al.. (2003). HIV‐Related Hodgkin's disease with central nervous system involvement and association with Epstein‐Barr virus. American Journal of Hematology. 72(3). 216–219. 15 indexed citations
11.
Udden, Mark M.. (2002). In Vitro Sub-Hemolytic Effects of Butoxyacetic Acid on Human and Rat Erythrocytes. Toxicological Sciences. 69(1). 258–264. 34 indexed citations
12.
Cooley, Linda D., David Sears, Mark M. Udden, Wilbur R. Harrison, & Kelty R. Baker. (2000). Donor cell leukemia: Report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature. American Journal of Hematology. 63(1). 46–53. 59 indexed citations
13.
Cooley, Linda D., David Sears, Mark M. Udden, Wilbur R. Harrison, & Kelty R. Baker. (2000). Donor cell leukemia: Report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature. American Journal of Hematology. 63(1). 46–53. 1 indexed citations
14.
Sears, David, et al.. (1997). Pure Red Cell Aplasia Associated With Hepatitis C Infection. The American Journal of the Medical Sciences. 314(2). 113–117. 6 indexed citations
15.
Alfrey, Clarence P., Lawrence Rice, Mark M. Udden, & T. B. Driscoll. (1997). Neocytolysis: physiological down-regulator of red-cell mass. The Lancet. 349(9062). 1389–1390. 126 indexed citations
16.
Syed, Samira, David Sears, Jochewed Werch, Mark M. Udden, & John D. Milam. (1996). Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease. The American Journal of the Medical Sciences. 312(4). 175–181. 17 indexed citations
17.
Alfrey, Clarence P., Mark M. Udden, Carolyn L. Huntoon, & T. B. Driscoll. (1996). Destruction of newly released red blood cells in space flight. Medicine & Science in Sports & Exercise. 28(10). 42–44. 49 indexed citations
18.
Udden, Mark M., et al.. (1995). Decreased production of red blood cells in human subjects exposed to microgravity.. PubMed. 125(4). 442–9. 59 indexed citations
19.
20.
Wick, Timothy M., et al.. (1993). Unusually large von willebrand factor multimers preferentially promote young sickle and nonsickle erythrocyte adhesion to endothelial cells. American Journal of Hematology. 42(3). 284–292. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joan‐Lluís Vives Corrons Breakdown of academic impact, for papers by Tor Olofsson Breakdown of academic impact, for papers by Claudio Sandoval Breakdown of academic impact, for papers by W Fried Breakdown of academic impact, for papers by Michael Jeng Breakdown of academic impact, for papers by M. C. Brain Breakdown of academic impact, for papers by Louis D. Wadsworth Breakdown of academic impact, for papers by A. J. Bellingham Breakdown of academic impact, for papers by Maurizio Sampietro Breakdown of academic impact, for papers by DG Nathan
Rankless by CCL
2026